BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6124951)

  • 1. Modification of d-amphetamine- or chlorpromazine-induced hypothermia by beta-endorphin, MIF-I, and alpha-MSH: mediation by the dopaminergic system.
    Yehuda S; Carasso RL
    Peptides; 1982; 3(2):105-10. PubMed ID: 6124951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures.
    Yehuda S; Kastin AJ
    Peptides; 1980; 1(3):243-8. PubMed ID: 6112734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of MIF-I, beta-endorphin and alpha-MSH on d-amphetamine induced paradoxical behavioral thermoregulation: possible involvement of the dopaminergic system.
    Yehuda S; Sheleff P
    Peptides; 1985; 6(2):189-92. PubMed ID: 2863810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides and thermoregulation.
    Yehuda S; Kastin AJ
    Neurosci Biobehav Rev; 1980; 4(4):459-71. PubMed ID: 6110198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible role of dopamine in phenothiazine-induced hypothermia in rats: an application to DA hypothesis of schizophrenia.
    Yehuda S; Frommer R
    Int J Neurosci; 1977; 7(2):67-72. PubMed ID: 19369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-Amphetamine-induced hypothermia and hypermotility in rats: changes after systemic administration of beta-endorphin.
    Yehuda S; Zadina J; Kastin AJ; Coy DH
    Peptides; 1980; 1(2):179-85. PubMed ID: 7243618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine.
    Yehuda S; Kastin AJ; Coy DH
    Int J Neurosci; 1980; 11(4):317-20. PubMed ID: 6108937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of alpha-MSH and MIF-I with amphetamine on open-field behavior of rats.
    Sandman CA; Kastin AJ
    Pharmacol Biochem Behav; 1978 Dec; 9(6):759-62. PubMed ID: 34173
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in circadian rhythms of thermoregulation and motor activity in rats as a function of aging: effects of d-amphetamine and alpha-MSH.
    Yehuda S; Carasso RL
    Peptides; 1983; 4(6):865-9. PubMed ID: 6672792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic neurons in the nigro-striatal and mesolimbic pathways: mediation of specific effects of D-amphetamine.
    Yehuda S; Wurtman RJ
    Eur J Pharmacol; 1975 Feb; 30(2):154-8. PubMed ID: 1168575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN
    J Pharmacol Exp Ther; 1981 Aug; 218(2):404-8. PubMed ID: 6114170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-melanocyte stimulating hormone discloses a stimulatory effect of beta-endorphin on somatostatin release.
    Aguila MC; Khorram O; McCann SM
    Brain Res; 1987 Aug; 417(1):127-30. PubMed ID: 2887255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the hypothermic effects of methylphenidate and d-amphetamine.
    Yehuda S; Ben-Uriah Y; Carasso RL
    Int J Neurosci; 1981; 13(2-3):117-20. PubMed ID: 7239782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gamma-type endorphins on alpha-MSH release in the rat.
    de Rotte AA; van Wimersma Greidanus TB; van de Buuse M; Andringa-Bakker EA; de Wied D
    Life Sci; 1985 Jul; 37(3):263-71. PubMed ID: 2409428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSH and MIF-I in animal models of tardive dyskinesia.
    Davis KL; Kastin AJ; Beilstein BA; Vento AL
    Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of beta-LPH fragments on alpha-MSH release: the involvement of a dopaminergic system.
    de Rotte AA; van Wimersma Greidanus TB; van Ree JM; Andringa-Bakker EA; de Wied D
    Life Sci; 1981 Aug; 29(8):825-32. PubMed ID: 6170858
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
    Cox B; Kastin AJ; Schnieden H
    Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-MSH, MIF-I and melatonin: effects on novelty-induced defecation, plasma 11-OHCS and central catecholamines in rats.
    Datta PC; King MG
    Peptides; 1981; 2 Suppl 1():143-54. PubMed ID: 6115365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas.
    Kostrzewa RM; Kastin AJ; Spirtes MA
    Pharmacol Biochem Behav; 1975; 3(6):1017-23. PubMed ID: 4815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of alpha-melanocyte-stimulating hormone with beta-endorphin to influence anterior pituitary hormone secretion in the female rat.
    Khorram O; McCann SM
    Endocrinology; 1986 Sep; 119(3):1071-5. PubMed ID: 2942393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.